Apr 4, 2025· Comment from Parenteral Drug Association· FDA-2024-D-5374-0007
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2024-D-5374
Considerations for Complying With 21 CFR 211.110; Draft Guidance for Industry; Availability
RIN
—
Last modified
Mar 18, 2025
Comment window
closed 477d ago
Parenteral Drug Association filings
1
Activity
Parenteral Drug Association filed 1 comment on this docket between Apr 4, 2025 and Apr 4, 2025. 0 other organizations filed here. The comment window closed 477d ago.
What Parenteral Drug Association filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (0)
See everyone who commented →- Parenteral Drug AssociationTHIS ORG1 filing · confidence 97%